Amyotrophic lateral sclerosis (ALS) is an incurable and fatal neurodegenerative disease, which is caused by a C9orf72 repeat expansion in 9% of the cases. This mutation may cause changes of brain metabolism in patients but whether it affects brain metabolism in pre-symptomatic mutation carriers was not studied before. We used 7 Tesla magnetic resonance spectroscopic imaging (MRSI) to study brain metabolism in asymptomatic carriers of the C9orf72 repeat expansion and found lower concentrations of glutamate and N-acetylaspartate+N-acetylaspartylglutamate in the left putamen compared to non-carriers. This might indicate asymptomatic neuronal loss, a developmental defect or possibly a protective mechanism against ALS.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords